It has been reported that the cancellation standards of 'Innovative Pharmaceutical Companies Certification' will be relaxed for pharmaceutical companies fined for rebates.

Some argue that certification requirements for illegal rebates are strict. Further criticism is anticipated as these measures deviate from the government’s longstanding anti-rebate policies.

On December 4, the government finalized the "Innovate Economic Regulatory Plan for Enhancing Corporate Dynamism and Promoting New Industries" at the Emergency Ministerial Meeting on Economic Affairs. This plan was prepared by the Ministry of Economy and Finance and the Office for Government Policy Coordination of South Korea, acti